Xilio Therapeutics, Inc.
XLO
$1.04
$0.139915.54%
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
--
Headlines
11/9/2023
-
TipRanks Financial Blog
11/9/2023
-
The Fly
11/9/2023
-
Globe Newswire
11/7/2023
-
The Fly
11/3/2023
-
Globe Newswire
10/20/2023
-
Zolmax
9/27/2023
-
Globe Newswire
9/27/2023
-
Zolmax
9/6/2023
-
Ticker Report
9/5/2023
-
The Fly
9/5/2023
-
Globe Newswire
9/5/2023
-
Globe Newswire
9/5/2023
-
Zolmax
8/15/2023
-
Ticker Report
8/14/2023
-
SeekingAlpha.com: All News
8/14/2023
-
The Fly
Xilio Therapeutics Announces Pipeline and Business Updates and Second Quarter 2023 Financial Results
8/14/2023
-
Globe Newswire
8/3/2023
-
Globe Newswire
7/17/2023
-
Zolmax
7/16/2023
-
Ticker Report
7/15/2023
-
Zolmax
7/13/2023
-
Ticker Report
7/4/2023
-
Ticker Report
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Thursday, November 9, 2023
Period Date
Saturday, September 30, 2023
Next Filing
Beginning of March (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
--
5-Year Total Return
--
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
--
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
857 524 2466
Address
828 Winter Street
Waltham, MA 02451
Waltham, MA 02451
Country
Year Founded
Business Description
Sector
Xilio Therapeutics, Inc., a clinical-stage biotechnology company, discovers and develops tumor-activated immuno-oncology therapies. Its checkpoint inhibitor program includes XTX101, an...
more
